Tags Archives: continuous renal replacement therapy

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is considered a recognized lifesaving support for patients with cardiorespiratory failure. Acute kidney injury (AKI) and fluid overload are significant morbidity factors resulting in serious..

Perfusfind S.L.

Abstract Objective:  To assess the safety and efficacy of combining extracorporeal CO2 removal with continuous renal replacement therapy in patients presenting with acute respiratory distress syndrome and acute kidney injury. Design: ..

Perfusfind S.L.

Abstract Background  (HES) solutions increase the risk of  (AKI) in critically ill patients admitted to intensive care unit (ICU) for medical indications. We conducted a cohort study to evaluate the renal..

Perfusfind S.L.

Super lecture and discussion around management of the Critical Care Unit patient.  Common problems if the ICU patient.  What is the role of the CRRT (Continuous Renal Replacement Therapy).  Mostly..

Perfusfind S.L.

CVVH/CRRT: What Is It And Why We Should Use It More.Continuous Renal Replacement Therapy. Veno-Venous Hemofiltration. Discussion on fluid balance and mortality.  

Perfusfind S.L.

Kimberlee Spurlin, RN lectures and discusses the use of Continuous Renal Replacement Therapy (CRRT) and Continuous Veno Venous Hemofiltration (CVVH) integrated into the ECMO circuit. CRRT fundamentals.  Extracorporeal Membrane Oxygenation..

Perfusfind S.L.

Abstract Extracorporeal circuits including renal replacement therapy, extracorporeal membrane oxygenation, and ventricular assist devices are increasingly used in critically ill patients. The need for anticoagulation to provide circuit patency and..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is a temporary life support system used to assist patients with life-threatening severe cardiac and/or respiratory insufficiency. Patients requiring ECMO can be considered the sickest..

Perfusfind S.L.

Abstract Children show important developmental and maturational changes, which may contribute greatly to pharmacokinetic (PK) variability observed in pediatric patients. These PK alterations are further enhanced by disease-related, non-maturational factors...

Perfusfind S.L.

Abstract Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is the rescue treatment proposed to patients with refractory cardiogenic shock. The VA-ECMO implantation promotes inflammation and ischemia-reperfusion injuries through the VA-ECMO flow, causing..

Perfusfind S.L.

Abstract The number of patients using critical care is increasing as our populations live longer thanks to advances in medical therapies. This is reflected by an increase in both usage..

Perfusfind S.L.

Abstract Objectives In patients with idiopathic pulmonary arterial hypertension, cardiac function can be impaired in the early  after  because the chronically untrained  is prone to fail. Thus, restrictive fluid management is pivotal to..